TrialBlood advances2023

Guadecitabine vs treatment choice in newly diagnosed acute myeloid leukemia: a global phase 3 randomized study.

Pierre Fenaux et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.